Accumulated Depreciation
West Pharmaceutical Services Accumulated Depreciation increased by 1.6% to $1.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $1.37B to $1.52B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows an upward trend with a 6.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising balance relative to gross assets suggests an aging infrastructure, potentially signaling a need for future capital expenditure to replace equipment.
Detailed definition
This is the cumulative amount of depreciation expense charged against the company's tangible assets since their acquisit...
Peer comparison
Commonly found in the balance sheet or notes for all companies with significant physical property, plant, and equipment.
ppe_accumulated_depreciationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.13B | $1.14B | $1.16B | $1.17B | $1.17B | $1.16B | $1.23B | $1.26B | $1.28B | $1.30B | $1.32B | $1.34B | $1.37B | $1.42B | $1.40B | $1.37B | $1.46B | $1.49B | $1.50B | $1.52B |
| QoQ Change | — | +1.3% | +1.6% | +1.2% | -0.2% | -0.4% | +5.5% | +2.9% | +1.4% | +1.1% | +2.3% | +1.4% | +2.0% | +3.6% | -1.1% | -2.2% | +6.0% | +2.5% | +0.3% | +1.6% |
| YoY Change | — | — | — | — | +3.8% | +2.1% | +6.1% | +7.9% | +9.7% | +11.3% | +7.8% | +6.3% | +6.9% | +9.6% | +6.0% | +2.3% | +6.3% | +5.1% | +6.6% | +10.7% |
| % of PP&E (Net) | 115.6% | 113.2% | 109.5% | 109.9% | 108.5% | 108.9% | 106.0% | 104.0% | 101.6% | 98.8% | 93.7% | 92.7% | 91.7% | 90.4% | 88.8% | 84.2% | 84.5% | 85.7% | 86.7% | 89.3% |
| Share Change | — | -2.4pp | -3.8pp | +0.4pp | -1.4pp | +0.4pp | -2.8pp | -2.1pp | -2.3pp | -2.9pp | -5.0pp | -1.0pp | -1.0pp | -1.3pp | -1.6pp | -4.6pp | +0.3pp | +1.2pp | +1.0pp | +2.6pp |
Accumulated Depreciation at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's accumulated depreciation?
- West Pharmaceutical Services (WST) reported accumulated depreciation of $1.52B in Q1 2026.
- How has West Pharmaceutical Services's accumulated depreciation changed year-over-year?
- West Pharmaceutical Services's accumulated depreciation increased by 10.7% year-over-year, from $1.37B to $1.52B.
- What is the long-term trend for West Pharmaceutical Services's accumulated depreciation?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's accumulated depreciation has grown at a 6.5% compound annual growth rate (CAGR), from $1.09B to $1.50B.
- What does accumulated depreciation mean?
- The total amount of depreciation recorded against physical assets over time.